Cafepharma Today

November 4 2024 - AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
AstraZeneca says experimental obesity pill safe and tolerable in early-stage trial
50% of US drug shortages last at least 2 years: ASHP
Pharmas ask appeals court to reconsider IRA lawsuits
Wegovy reduces all-cause admissions: 3 study findings
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

New FDA labels may protect drug makers
The News Journal, DE
Sunday, August 24, 2008 - 10:23am
tags:
FDA Approves ALOXI(R) (Palonosetron HCl) Capsules For Prevention Of Acute Chemotherapy Induced Nausea And Vomiting
Medical News Today
Sunday, August 24, 2008 - 10:22am
tags:
Long Uphill Climb Continues For Genetics Firms
Yahoo/Investors Business Daily
Saturday, August 23, 2008 - 2:07pm
tags:
Don't Worry About Vytorin's Cancer Risk
Motley Fool
Saturday, August 23, 2008 - 10:47am
tags:
Salix Pharmaceuticals Sells $60 Million Of Convertible Notes
Trading Markets
Saturday, August 23, 2008 - 10:43am
tags:
GSK to provide public with more information
San Antonio Business Journal, TX
Saturday, August 23, 2008 - 10:42am
tags:
PharmaGap Closes $1.1 million Public Portion of Anticipated $2.6 million Equity Financing; Announces Full Clinical Development Group to Take Lead Cancer Drug into Human Clinical Trials
CNW Telbec
Saturday, August 23, 2008 - 10:41am
tags:
Angiotech Announces Extension of the Expiration Date of its Tender Offer for Senior Floating Rate Notes Due 2013 and 7.75% Senior Subordinated Notes Due 2014
CNW Telbec, Canada
Saturday, August 23, 2008 - 10:39am
tags:
FDA wants clear drug labels
Allentown Morning Call, PA
Saturday, August 23, 2008 - 10:37am
tags:
Owning Abbott shares a 'badge of honor'
Waukegan News Sun, IL
Saturday, August 23, 2008 - 10:35am
tags:
Cymbalta Receives European Approval For The Treatment Of Generalised Anxiety Disorder
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
Indevus Pharmaceuticals Announces Completion Of Enrollment In Phase III Trial Of PRO 2000
Medical News Today
Saturday, August 23, 2008 - 10:32am
tags:
FDA Needs Nine More Months to Study Vytorin, Cancer Link
MedHeadlines
Saturday, August 23, 2008 - 10:30am
tags:
Health Winners & Losers: Alpharma
Yahoo/TheStreet.com
Friday, August 22, 2008 - 7:23pm
tags:
BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Friday, August 22, 2008 - 7:22pm
tags:
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Friday, August 22, 2008 - 7:21pm
tags:
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Friday, August 22, 2008 - 7:20pm
tags:
King Pharma raises pressure on rival
Financial Times
Friday, August 22, 2008 - 7:19pm
tags:
Abbott Tries a Crash Diet
Motley Fool
Friday, August 22, 2008 - 4:27pm
tags:
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Friday, August 22, 2008 - 3:18pm
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes
Drug Channels
Eli Lilly's Earnings
In the Pipeline
The Choice
In the Pipeline
Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments
Drug Channels
GLP-1 For Everything
In the Pipeline
No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
Drug Channels
A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Morgantown, WV
Morgantown, West Virginia, 26501
Otsuka
Territory Manager, Medical Dermatology - Omaha, NE
Julian, Nebraska, 68379
Sun Pharmaceutical Industries, Inc.
Pharmaceutical Sales Customer Engagement- Tampa
Tampa, Florida, 33646
Otsuka
Pharmaceutical Sales Customer Engagement- Washington, DC
Washington, District of Columbia, 20022
Otsuka
Pharmaceutical Sales Customer Engagement - Eugene, OR
Eugene, Oregon, 97403
Otsuka
Pharmaceutical Sales Customer Engagement - Atlanta East, GA
Atlanta, Georgia, 30383
Otsuka
Pharmaceutical Sales Customer Engagement- Columbus, OH
Columbus, Ohio, 43224
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Baltimore S, MD
Baltimore, Maryland, 21276
Otsuka
Pharmaceutical Sales Customer Engagement, CNS - Allentown, PA
Allentown, Pennsylvania, 18103
Otsuka
Territory Manager, Medical Dermatology - Sacramento, CA
Clarksburg, California, 95612
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information